• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人基质金属蛋白酶-8基因传递增强了复制型腺病毒的溶瘤活性。

Human matrix metalloproteinase-8 gene delivery increases the oncolytic activity of a replicating adenovirus.

作者信息

Cheng Jin, Sauthoff Harald, Huang YaoQi, Kutler David I, Bajwa Sofia, Rom William N, Hay John G

机构信息

Division of Pulmonary and Critical Care Medicine, New York University School of Medicine, New York, New York 10016, USA.

出版信息

Mol Ther. 2007 Nov;15(11):1982-90. doi: 10.1038/sj.mt.6300264. Epub 2007 Jul 24.

DOI:10.1038/sj.mt.6300264
PMID:17653103
Abstract

The success of replicating adenoviruses for cancer therapy is limited by inefficient virus delivery and poor distribution within the tumor mass. Stromal matrix within the tumor may hinder the free cell-to-cell spread of the virus. In this study, in vitro cell culture experiments showed that collagen I blocked the passage of an adenoviral vector through a membrane. On the basis of reports of the effective collagen I-degrading activity of matrix metalloproteinase-8 (MMP-8), we constructed an adenovirus to express the MMP-8 transgene (AdMMP8). A549 cells infected in vitro with AdMMP8 did not show altered growth but were able to modify a fibrillar collagen substrate to allow viral diffusion. Further, AdMMP8 did not affect replication of the wild-type virus (Adwt300). Established human A549 lung cancer and BxPC-3 pancreatic cancer xenograft tumors that were injected with Adwt300 together with the non-replicating AdMMP8 virus showed significantly reduced growth compared with control tumors. Histochemical analysis showed reduced amounts of collagen within necrotic areas of MMP-8-injected tumors compared with controls. These results demonstrate that intra-tumoral expression of MMP-8 is a possible strategy for improving viral spread and improving the oncolytic activity of replicating adenovirus.

摘要

用于癌症治疗的腺病毒复制的成功受到病毒递送效率低下和在肿瘤块内分布不佳的限制。肿瘤内的基质可能会阻碍病毒在细胞间的自由传播。在本研究中,体外细胞培养实验表明,I型胶原可阻止腺病毒载体通过膜。基于基质金属蛋白酶-8(MMP-8)有效降解I型胶原活性的报道,我们构建了一种表达MMP-8转基因的腺病毒(AdMMP8)。体外感染AdMMP8的A549细胞生长未发生改变,但能够改变纤维状胶原底物以允许病毒扩散。此外,AdMMP8不影响野生型病毒(Adwt300)的复制。与对照肿瘤相比,注射Adwt300和非复制型AdMMP8病毒的已建立的人A549肺癌和BxPC-3胰腺癌异种移植肿瘤生长显著减缓。组织化学分析显示,与对照相比,注射MMP-8的肿瘤坏死区域内的胶原量减少。这些结果表明,肿瘤内表达MMP-8是改善病毒传播和提高复制型腺病毒溶瘤活性的一种可能策略。

相似文献

1
Human matrix metalloproteinase-8 gene delivery increases the oncolytic activity of a replicating adenovirus.人基质金属蛋白酶-8基因传递增强了复制型腺病毒的溶瘤活性。
Mol Ther. 2007 Nov;15(11):1982-90. doi: 10.1038/sj.mt.6300264. Epub 2007 Jul 24.
2
Treatment with human metalloproteinase-8 gene delivery ameliorates experimental rat liver cirrhosis.用人金属蛋白酶-8基因传递进行治疗可改善实验性大鼠肝硬化。
Gastroenterology. 2004 Apr;126(4):1122-33; discussion 949. doi: 10.1053/j.gastro.2003.12.045.
3
Tissue inhibitor of metalloproteinase-3 expression from an oncolytic adenovirus inhibits matrix metalloproteinase activity in vivo without affecting antitumor efficacy in malignant glioma.来自溶瘤腺病毒的金属蛋白酶组织抑制剂-3表达可在体内抑制基质金属蛋白酶活性,而不影响对恶性胶质瘤的抗肿瘤疗效。
Cancer Res. 2005 Oct 15;65(20):9398-405. doi: 10.1158/0008-5472.CAN-04-4264.
4
Hypoxia reduces adenoviral replication in cancer cells by downregulation of viral protein expression.
Gene Ther. 2005 Jun;12(11):911-7. doi: 10.1038/sj.gt.3302459.
5
Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.用表达单纯疱疹病毒胸苷激酶的复制型腺病毒载体治疗恶性胶质瘤。
Cancer Res. 2001 Dec 15;61(24):8743-50.
6
Intratumoral spread of wild-type adenovirus is limited after local injection of human xenograft tumors: virus persists and spreads systemically at late time points.野生型腺病毒在局部注射人异种移植肿瘤后,瘤内传播受限:病毒在晚期时间点持续存在并发生全身扩散。
Hum Gene Ther. 2003 Mar 20;14(5):425-33. doi: 10.1089/104303403321467199.
7
A novel immunocompetent murine model for replicating oncolytic adenoviral therapy.一种用于复制溶瘤腺病毒疗法的新型免疫健全小鼠模型。
Cancer Gene Ther. 2015 Jan;22(1):17-22. doi: 10.1038/cgt.2014.64. Epub 2014 Dec 19.
8
Late expression of p53 from a replicating adenovirus improves tumor cell killing and is more tumor cell specific than expression of the adenoviral death protein.来自复制型腺病毒的p53晚期表达可增强肿瘤细胞杀伤作用,且比腺病毒死亡蛋白的表达更具肿瘤细胞特异性。
Hum Gene Ther. 2002 Oct 10;13(15):1859-71. doi: 10.1089/104303402760372954.
9
In vivo imaging of adenovirus transduction and enhanced therapeutic efficacy of combination therapy with conditionally replicating adenovirus and adenovirus-p27.腺病毒转导的体内成像以及条件性复制腺病毒与腺病毒-p27联合治疗的增强治疗效果
Cancer Res. 2006 Jan 1;66(1):372-7. doi: 10.1158/0008-5472.CAN-05-1515.
10
Wild-type adenovirus decreases tumor xenograft growth, but despite viral persistence complete tumor responses are rarely achieved--deletion of the viral E1b-19-kD gene increases the viral oncolytic effect.野生型腺病毒可降低肿瘤异种移植瘤的生长,但尽管病毒持续存在,却很少能实现完全的肿瘤反应——删除病毒E1b-19-kD基因可增强病毒的溶瘤作用。
Hum Gene Ther. 2001 Jul 1;12(10):1323-32. doi: 10.1089/104303401750270977.

引用本文的文献

1
Relaxin-2-secreting CAR-T cells exhibit enhanced efficacy in stromal-rich xenograft tumors.分泌松弛素-2的嵌合抗原受体T细胞在富含基质的异种移植肿瘤中表现出增强的疗效。
Front Immunol. 2025 Jul 1;16:1506204. doi: 10.3389/fimmu.2025.1506204. eCollection 2025.
2
Extracellular matrix re-normalization to improve cold tumor penetration by oncolytic viruses.细胞外基质重新归一化以改善溶瘤病毒对冷肿瘤的渗透。
Front Immunol. 2025 Jan 8;15:1535647. doi: 10.3389/fimmu.2024.1535647. eCollection 2024.
3
Theranostic nanoparticles for detection and treatment of pancreatic cancer.
用于胰腺癌检测与治疗的诊疗纳米颗粒。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024 Jul-Aug;16(4):e1983. doi: 10.1002/wnan.1983.
4
Multiple aspects of matrix stiffness in cancer progression.癌症进展中基质刚度的多个方面。
Front Oncol. 2024 Jul 2;14:1406644. doi: 10.3389/fonc.2024.1406644. eCollection 2024.
5
An Update on the Clinical Status, Challenges, and Future Directions of Oncolytic Virotherapy for Malignant Gliomas.恶性脑胶质瘤溶瘤病毒治疗的临床现状、挑战与未来方向的更新。
Curr Treat Options Oncol. 2024 Jul;25(7):952-991. doi: 10.1007/s11864-024-01211-6. Epub 2024 Jun 19.
6
A Recombinant Oncolytic Pseudorabies Virus Expressing , and Genes Promotes Systemic Antitumor Immunity.一种表达、和基因的重组溶瘤伪狂犬病病毒促进全身抗肿瘤免疫。
Microorganisms. 2023 Jul 21;11(7):1850. doi: 10.3390/microorganisms11071850.
7
Strategies for Efficient Targeting of Tumor Collagen for Cancer Therapy.癌症治疗中高效靶向肿瘤胶原蛋白的策略。
Cancers (Basel). 2022 Sep 27;14(19):4706. doi: 10.3390/cancers14194706.
8
Agent-based computational modeling of glioblastoma predicts that stromal density is central to oncolytic virus efficacy.基于主体的胶质母细胞瘤计算模型预测,基质密度对溶瘤病毒疗效至关重要。
iScience. 2022 May 13;25(6):104395. doi: 10.1016/j.isci.2022.104395. eCollection 2022 Jun 17.
9
Beyond cancer cells: Targeting the tumor microenvironment with gene therapy and armed oncolytic virus.超越癌细胞:利用基因治疗和武装溶瘤病毒靶向肿瘤微环境。
Mol Ther. 2021 May 5;29(5):1668-1682. doi: 10.1016/j.ymthe.2021.04.015. Epub 2021 Apr 19.
10
Combining Oncolytic Viruses with Chimeric Antigen Receptor T Cell Therapy.溶瘤病毒联合嵌合抗原受体 T 细胞疗法。
Hum Gene Ther. 2021 Feb;32(3-4):150-157. doi: 10.1089/hum.2020.278.